BR9405713A - Diagnose de leishmaniose - Google Patents

Diagnose de leishmaniose

Info

Publication number
BR9405713A
BR9405713A BR9405713A BR9405713A BR9405713A BR 9405713 A BR9405713 A BR 9405713A BR 9405713 A BR9405713 A BR 9405713A BR 9405713 A BR9405713 A BR 9405713A BR 9405713 A BR9405713 A BR 9405713A
Authority
BR
Brazil
Prior art keywords
leishmania
sample
recombinant
repeat unit
detecting
Prior art date
Application number
BR9405713A
Other languages
English (en)
Inventor
Steven G Reed
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR9405713A publication Critical patent/BR9405713A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/822—Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Soft Magnetic Materials (AREA)
  • Power Conversion In General (AREA)
BR9405713A 1993-01-15 1994-01-10 Diagnose de leishmaniose BR9405713A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/006,676 US5411865A (en) 1993-01-15 1993-01-15 Method of detecting anti-leishmania parasite antibodies
PCT/US1994/000324 WO1994016331A1 (en) 1993-01-15 1994-01-10 Diagnosis of leishmaniasis

Publications (1)

Publication Number Publication Date
BR9405713A true BR9405713A (pt) 1995-11-28

Family

ID=21722052

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9405713A BR9405713A (pt) 1993-01-15 1994-01-10 Diagnose de leishmaniose

Country Status (8)

Country Link
US (2) US5411865A (pt)
EP (1) EP0679259B1 (pt)
AT (1) ATE178355T1 (pt)
BR (1) BR9405713A (pt)
DE (1) DE69417541T2 (pt)
ES (1) ES2129630T3 (pt)
GR (1) GR3029983T3 (pt)
WO (1) WO1994016331A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705358B1 (fr) * 1993-05-13 1995-08-04 Orstom Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques.
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en) 1995-09-22 2002-04-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US5834592A (en) * 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6638517B2 (en) 1995-09-22 2003-10-28 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US5846748A (en) * 1996-11-15 1998-12-08 The Council Of Scientific & Industrial Research Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate
US6458359B1 (en) * 1998-12-23 2002-10-01 C.B.F. Leti S.A. Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans
US20040241168A1 (en) * 2001-03-16 2004-12-02 O'daly Jose A. Compositions and methods for the treatment and clinical remission of psoriasis
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
AU2003288711A1 (en) * 2003-12-26 2005-07-21 All India Institute Of Medical Sciences Polypeptides for the diagnosis and therapy of leishmaniasis
WO2006110915A2 (en) * 2005-04-15 2006-10-19 University Of Iowa Research Foundation Vaccine formulations for leishmania
BRPI0710155A2 (pt) * 2006-04-10 2011-08-23 Infectious Disease Res Inst Inc compostos e métodos para diagnóstico e tratamento de leishmaniose
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
DK2068918T4 (da) 2006-09-26 2024-09-02 Access To Advanced Health Inst Vaccinesammensætning omfattende syntetisk adjuvant
US20100304461A1 (en) * 2007-06-12 2010-12-02 Brandis John W Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli
WO2009158729A2 (en) * 2008-06-27 2009-12-30 The Infectious Disease Research Institute Inc. Compounds and methods for diagnosis and treatment of chagas disease
BRPI0913972B1 (pt) 2008-07-03 2018-06-26 Infectious Disease Research Institute Polipeptídeo de fusão compreendendo antígenos de leishmania, polinucleotídeo, composição farmacêutica, bem como métodos para detecção de infecção e para identificação de leishmaniose e kit diagnóstico para detecção e identificação de leishmaniose
EP3124491B1 (en) * 2009-06-05 2019-10-30 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions as well as pharmaceutical compositions containing them
BRPI1003744B1 (pt) * 2010-06-08 2021-10-26 Universidade Federal De Ouro Preto E-ntpdases recombinantes, uso na produção de kit de diagnóstico para detecção de anticorpos nas leishmanioses causadas por espécies do gênero leishmania
JP6054942B2 (ja) 2011-04-08 2016-12-27 イミューン デザイン コーポレイション 免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法
PL2811981T3 (pl) 2012-02-07 2019-09-30 Infectious Disease Research Institute Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
CN107540730B (zh) 2012-05-16 2021-07-16 免疫设计公司 用于hsv-2的疫苗
EP2756850A1 (en) * 2013-01-18 2014-07-23 Philipps-Universität Marburg Diagnosis of Leishmania infection
ES2728865T3 (es) 2013-03-28 2019-10-29 Infectious Disease Res Inst Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
KR102411781B1 (ko) 2013-12-31 2022-06-22 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) 단일 바이알 백신 제형
WO2016055836A1 (pt) * 2014-10-09 2016-04-14 Universidade Federal De Minas Gerais - Ufmg Processo de produção e uso da proteína rk39-kddr e kit para diagnóstico de leishmaniose
WO2017210364A1 (en) 2016-06-01 2017-12-07 Infectious Disease Research Institute Nanoalum particles containing a sizing agent
AU2020283768A1 (en) 2019-05-25 2021-12-23 Access To Advanced Health Institute Composition and method for spray drying an adjuvant vaccine emulsion
EP4215916A1 (de) * 2022-01-20 2023-07-26 Philipps-Universität Marburg Test zum nachweis von antikörpern gegen leishmanien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0197062B1 (fr) * 1984-10-01 1991-01-09 Institut Pasteur Anticorps monoclonaux anti-leishmania, hybridomes secreteurs de ces anticorps, antigenes de leishmania reconnus par ces anticorps, procede d'obtention et applications de ces anticorps monoclonaux et de ces antigenes
IL82740A0 (en) * 1987-06-01 1987-12-20 Yeda Res & Dev Assay for leishmaniasis
FR2619220B1 (fr) * 1987-08-03 1993-03-26 Pasteur Institut Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.
GB8921937D0 (en) * 1989-09-28 1989-11-15 Howard Michael K Diagnostic reagents for leishmaniasis

Also Published As

Publication number Publication date
DE69417541D1 (de) 1999-05-06
DE69417541T2 (de) 1999-07-15
EP0679259A4 (en) 1997-06-18
GR3029983T3 (en) 1999-07-30
ES2129630T3 (es) 1999-06-16
WO1994016331A1 (en) 1994-07-21
US5411865A (en) 1995-05-02
US5719263A (en) 1998-02-17
EP0679259B1 (en) 1999-03-31
ATE178355T1 (de) 1999-04-15
EP0679259A1 (en) 1995-11-02

Similar Documents

Publication Publication Date Title
BR9405713A (pt) Diagnose de leishmaniose
ES8606653A1 (es) Un metodo para la preparacion de una proteina que esta cova-lentemente acoplada a un extremo de un acido nucleico
FI902143A0 (fi) Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.
KR850006548A (ko) 프리(pre)-S 유전자 코우드로 된 펩티드 B형 간염 면역원, 왁찐, 진단법 및 합성지질소낭 담체
ATE69890T1 (de) Nachweis von antigen aktiven aminosaeurensequenzen.
EP1264890A3 (en) Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
ES8801839A1 (es) Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids
AU7652194A (en) A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
EP0869177A3 (en) Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
Obinata et al. Immunochemical comparison of myosin light chains from chicken fast white, slow red, and cardiac muscle
PL316792A1 (en) Method of detecting presence of mycobacterium species and detecting set therefor as well as correspodning antibodies
KR920702688A (ko) Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로 부터 유도된 항체
ES8402939A1 (es) Procedimiento de analisis de ligacion especifica para determinar un analito en una muestra de ensayo.
DE69028784D1 (de) Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
EP0293827A3 (en) Assay for leishmaniasis
Obinata et al. The subunit structure of myosin from skeletal muscle of the early chick embryo
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
FR2722508B1 (fr) Cassette d'expression d'une proteine p30 de toxoplasma gondii
Michalski et al. Purification and characterisation of a serine-type protease from Eimeria tenella oocysts
PT93764A (pt) Processo para a preparacao de moleculas comportando pelo menos uma sequencia peptidica portadora de um, ou varios, epitopo(s) caracteristico(s) de uma proteina produzida por "p.falciparum" ao nivel do estadio esporozoito e nos hepatocitos
Zalis et al. Routine dot-blot assay of multiple serum samples using a simple apparatus
Michalski et al. Molecular characterisation of peanut agglutininbinding glycoproteins from Eimeria tenella
DE69011879D1 (de) Immuntestverfahren für zelluläres Eiweiss.

Legal Events

Date Code Title Description
FA Application withdrawn